BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22729151)

  • 1. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Yarchoan R
    Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
    Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
    Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
    Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
    Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
    Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.
    Polizzotto MN; Uldrick TS; Hu D; Yarchoan R
    Front Microbiol; 2012; 3():73. PubMed ID: 22403576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the treatment of human herpesvirus 8-associated disease.
    Casper C
    Rev Med Virol; 2008; 18(5):321-9. PubMed ID: 18615774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated multicentric Castleman disease.
    Oksenhendler E
    Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
    Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
    Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
    Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
    Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
    Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
    Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
    Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
    Ray A; Marshall V; Uldrick T; Leighty R; Labo N; Wyvill K; Aleman K; Polizzotto MN; Little RF; Yarchoan R; Whitby D
    J Infect Dis; 2012 Jun; 205(11):1665-76. PubMed ID: 22448005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
    Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
    Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat HHV8/KSHV-related diseases in posttransplant patients.
    Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
    Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
    Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
    Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman disease: Where are we now?
    Wang HW; Pittaluga S; Jaffe ES
    Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.